Macerich Co
MAC NYSE Real Estate Investment Trusts Financials FY2016βFY2025
What Macerich Co does
No business description yet.
- Legal name
- MACERICH CO
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 20, 2026
- Accession Β· CIK
- 0000912242-26-000016
0000912242
Revenue and margins
Macerich Co had $1.0B of revenue in fiscal 2025, up 10.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Macerich Co returned $188M to shareholders in fiscal 2025. The diluted share count rose 14.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Macerich Co can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $112M | $100M | $94.9M | $89.9M | $280M |
| Debt incl. finance leases | $4.4B | $4.3B | $4.1B | $4.9B | $5.1B |
| Debt / equity | 1.5x | 1.5x | 1.7x | 1.8x | 2.1x |
| Total assets | $8.3B | $8.1B | $7.5B | $8.6B | $8.4B |
| Total liabilities | $5.2B | $5.1B | $5.0B | $5.7B | $5.8B |
| Shareholders' equity | $3.0B | $2.9B | $2.4B | $2.8B | $2.4B |
| Net debt (β = net cash) | $4.3B | $4.2B | $4.1B | $4.8B | $4.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | 5 / 7 | 4 / 7 | 3 / 7 | 3 / 7 | 3 / 7 |
| Accruals ratio | 1.3% | β2.3% | β3.0% | β2.9% | β3.9% | β3.1% | β4.9% | β7.3% | β5.9% | β6.1% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.0B | $994M | $960M | $927M | $786M | $847M | $859M | $884M | $918M | $1.0B |
| Net interest income | β | β | β | β | β | β$193M | β$217M | β$173M | β$220M | β$284M |
| Interest expense | $164M | $172M | $183M | $138M | $75.6M | $193M | $217M | β | β | β |
| Income tax | $0.7M | $15.6M | β$3.6M | $1.6M | β$0.4M | $6.9M | $0.7M | β$0.5M | β$1.3M | β$2.2M |
| Net income | $555M | $162M | $69.0M | $96.8M | β$230M | $14.3M | β$66.1M | β$274M | β$194M | β$197M |
| Net income to common | $517M | $146M | $60.0M | $95.6M | β$231M | $13.4M | β$66.9M | β$275M | β$195M | β$198M |
| Diluted EPS | $3.52 | $1.02 | $0.42 | $0.68 | β$1.58 | $0.07 | β$0.31 | β$1.28 | β$0.88 | β$0.78 |
| Diluted shares | 0.15B | 0.14B | 0.14B | 0.14B | 0.15B | 0.20B | 0.22B | 0.22B | 0.22B | 0.25B |
| Cash flow | ||||||||||
| Cash from operations | $430M | $386M | $344M | $355M | $125M | $286M | $338M | $296M | $283M | $322M |
| Depreciation and amortization | $355M | $341M | $335M | $338M | $326M | $324M | $302M | $296M | $306M | $368M |
| Stock-based compensation | $33.3M | $30.8M | $27.4M | $12.0M | $13.8M | $14.3M | $17.6M | $13.2M | $12.1M | $18.2M |
| Share buybacks | $800M | $221M | $0.0M | $0.0M | β | β | β | β | β | β |
| Dividends paid | $779M | $444M | $454M | $475M | $180M | $143M | $186M | $159M | $161M | $188M |
| Dividends and buybacks | $1.6B | $665M | $454M | $475M | $180M | $143M | $186M | $159M | $161M | $188M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $94.0M | $91.0M | $103M | $100M | $465M | $112M | $100M | $94.9M | $89.9M | $280M |
| Total debt | β | β | β | β | $4.6B | $4.4B | $4.2B | $4.1B | $4.9B | $5.1B |
| Finance lease liabilities | β | β | $15.3M | $13.8M | $16.4M | $14.5M | $12.6M | $10.6M | $4.4M | β |
| Intangible assets | $84.0M | $59.9M | $46.2M | $32.4M | $48.1M | $35.6M | β | β | β | β |
| Total assets | $10.0B | $9.6B | $9.0B | $8.9B | $9.2B | $8.3B | $8.1B | $7.5B | $8.6B | $8.4B |
| Total liabilities | $5.5B | $5.6B | $5.8B | $6.0B | $6.7B | $5.2B | $5.1B | $5.0B | $5.7B | $5.8B |
| Shareholders' equity | $4.1B | $3.7B | $3.0B | $2.6B | $2.3B | $3.0B | $2.9B | $2.4B | $2.8B | $2.4B |
| Margins | ||||||||||
| Net margin | 53.3% | 16.3% | 7.2% | 10.4% | β29.3% | 1.7% | β7.7% | β31.0% | β21.1% | β19.4% |
| Net interest share of revenue | β | β | β | β | β | β22.7% | β25.2% | β19.6% | β24.0% | β28.0% |
| Returns | ||||||||||
| Return on equity | 13.5% | 4.2% | 2.1% | 3.5% | β9.4% | 0.5% | β2.2% | β10.3% | β7.5% | β7.6% |
| Return on assets | 5.6% | 1.7% | 0.7% | 1.1% | β2.6% | 0.2% | β0.8% | β3.5% | β2.4% | β2.3% |
| Return on tangible equity | 12.9% | 4.0% | 2.1% | 3.7% | β10.5% | 0.4% | β2.3% | β11.2% | β7.1% | β8.1% |
| Growth | ||||||||||
| Revenue growth | β | β4.6% | β3.4% | β3.4% | β15.2% | 7.8% | 1.4% | 2.9% | 3.9% | 10.4% |
| Net income growth | β | β70.9% | β57.3% | 40.4% | β337.8% | β | β563.2% | β | β | β |
| EPS growth | β | β71.0% | β58.8% | 61.9% | β332.4% | β | β542.9% | β | β | β |
| Share count change | β | β3.3% | β0.5% | 0.1% | 3.5% | 35.4% | 8.6% | 0.2% | 2.9% | 14.6% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | β | 2.0x | 1.5x | 1.5x | 1.7x | 1.8x | 2.1x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 3.2% | 3.1% | 2.8% | 1.3% | 1.8% | 1.7% | 2.1% | 1.5% | 1.3% | 1.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | 5.0 | 4.0 | 3.0 | 3.0 | 3.0 |
| Accruals ratio | 1.3% | β2.3% | β3.0% | β2.9% | β3.9% | β3.1% | β4.9% | β7.3% | β5.9% | β6.1% |
Source: SEC EDGAR XBRL filings (CIK 0000912242). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.